Oruka Therapeutics, Inc. ORKA Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $49.52M+5.5% | $46.94M-48.6% | $91.25M+39.5% | $65.4M-21.7% | $83.57M+35.7% | ||
| $107.12M-24.8% | $142.54M-6.1% | $151.76M+558% | $23.05M-3.8% | $23.95M+32.6% | ||
| $395.25M+14.9% | $343.86M-3.2% | $355.16M+7.0% | $332.01M-5.7% | $352.08M-6.6% | ||
| $318K+10.4% | $288K+13.8% | $253K+45.4% | $174K+9.4% | $159K-1.9% | ||
| —— | $2.94M— | —— | —— | —— | ||
| $504.48M+3.2% | $488.62M-4.1% | $509.25M+42.5% | $357.42M-5.2% | $377.11M-4.8% | ||
| $16.63M+8.2% | $15.37M-26.7% | $20.97M+73.1% | $12.11M+3.3% | $11.72M-10.1% | ||
| $17.76M+6.4% | $16.69M-25.7% | $22.46M+63.0% | $13.78M+11.2% | $12.39M-10.2% | ||
| 545M0.0% | 545M0.0% | 545M0.0% | 545M0.0% | 545M0.0% | ||
| -$220.98M-16.8% | -$189.16M-18.5% | -$159.57M-23.4% | -$129.3M-23.5% | -$104.72M-25.1% | ||
| $486.72M+3.1% | $471.93M-3.1% | $486.79M+41.7% | $343.64M-5.8% | $364.73M-4.6% | ||
| $504.48M+3.2% | $488.62M-4.1% | $509.25M+42.5% | $357.42M-5.2% | $377.11M-4.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Oruka Therapeutics, Inc.'s total assets?
- Oruka Therapeutics, Inc. (ORKA) holds $504.5M in total assets, up 33.8% year over year.
- How much debt does Oruka Therapeutics, Inc. have?
- Oruka Therapeutics, Inc. carries $1.8M in total debt against $486.7M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Oruka Therapeutics, Inc. have?
- Oruka Therapeutics, Inc. holds $49.5M in cash and equivalents.
- Can Oruka Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 23.76 — current assets exceed current liabilities.
- Where does Oruka Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Oruka Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.